tm logo
RESEARCH FOUNDATION FOR CURE INITIATIVES
Live/Pending
FINAL REFUSAL - MAILED

mailed

on 17 Oct 2024

Last Applicant/ Owned by

40 Remsen St, #4

New York

NY

11201

Serial Number

98099691 filed on 25th Jul 2023

Registration Number

N/A

Correspondent Address

Joyce Liou

Joyce Liou MORRISON & FOERSTER LLP

SAN FRANCISCO, CA 94105

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RESEARCH FOUNDATION FOR CURE INITIATIVES

Promoting public awareness of medical research, prevention, diagnosis, treatment, and cures for inheritable and acquired genetic disorders and diseases. Charitable fundraising, namely, organizing events and activities to generate funds to support medical research, awareness, prevention, diagnosis, treatment, and cure

Classification Information


Class [036]
Insurance & Financial Services


Charitable fundraising, namely, organizing events and activities to generate funds to support medical research, awareness, prevention, diagnosis, treatment, and cure


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [035]
Advertising, Business & Retail Services


Promoting public awareness of medical research, prevention, diagnosis, treatment, and cures for inheritable and acquired genetic disorders and diseases.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98099691

Mark Type

No Service Mark

Attorney Docket Number

No 873896006000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Oct 2024FINAL REFUSAL WRITTEN
17th Oct 2024NOTIFICATION OF FINAL REFUSAL EMAILED
17th Oct 2024FINAL REFUSAL E-MAILED
28th Jun 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
28th Jun 2024TEAS/EMAIL CORRESPONDENCE ENTERED
28th Jun 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
28th Mar 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
28th Mar 2024NON-FINAL ACTION E-MAILED
28th Mar 2024NON-FINAL ACTION WRITTEN
27th Mar 2024ASSIGNED TO EXAMINER